Navigation Links
CVS Caremark Appoints Dr. William Shrank as Chief Scientific Officer and Chief Medical Officer, Provider Innovation and Analytics
Date:11/12/2013

WOONSOCKET, R.I., Nov. 12, 2013 /PRNewswire/ -- CVS Caremark (NYSE: CVS) today announced the appointment of William Shrank, MD to the position of Chief Scientific Officer and Chief Medical Officer, Provider Innovation and Analytics.  In this role, Dr. Shrank will focus on the development of innovative pharmacy solutions to help improve the quality of care while lowering costs in order to help health care providers deliver services to distinct patient populations.  Dr. Shrank will oversee the company's overall research and clinical program development with the goal of delivering new methods of evaluating innovative programs and initiatives.

(Logo: http://photos.prnewswire.com/prnh/20090226/NE75914LOGO)

Dr. Shrank has extensive experience in pharmaceutical outcomes research and has published extensively on topics including the evaluation of various pharmacy benefit designs, the Medicare Part D Prescription Drug benefit, medication adherence for chronic conditions and ensuring high-quality patient communications regarding the risks and benefits of prescribed medications.  Prior to joining CVS Caremark, Dr. Shrank was a practicing physician with Brigham Internal Medicine Associates as well as an Assistant Professor at Harvard Medical School. Previously Dr. Shrank served as Director, Research and Rapid-Cycle Evaluation for the Center for Medicare & Medicaid Innovation at the Centers for Medicare & Medicaid Services (CMS).

"As CVS Caremark continues to focus on identifying and developing innovative pharmacy care programs that improve outcomes and reduce overall costs, Will's depth of experience as a researcher make him uniquely qualified to oversee our research agenda," commented Troyen A. Brennan, MD, MPH, Executive Vice President and Chief Medical Officer of CVS Caremark.  "His insights and expertise will enable us to continue to develop new solutions to improve care and quality for patients dealing with chronic disease."

"I look forward to working with the team at CVS Caremark to find new ways to further the company's research efforts," said Dr. Shrank. "To date, CVS Caremark has built a strong reputation as a leader in medication adherence research and we look forward to expanding upon this focus and uncovering new learnings to help our clients improve outcomes while managing cost."

Dr. Shrank received his Medical Degree from Cornell University Medical College, his Masters of Science degree in Health Services from the University of California at Los Angeles and his Bachelor's Degree from Brown University.

About CVS Caremark
CVS Caremark is dedicated to helping people on their path to better health as the largest integrated pharmacy company in the United States. Through the company's more than 7,600 CVS/pharmacy stores; its leading pharmacy benefit manager serving more than 60 million plan members; and its retail health clinic system, the largest in the nation with more than 750 MinuteClinic locations, it is a market leader in mail order, retail and specialty pharmacy, retail clinics, and Medicare Part D Prescription Drug Plans.  As a pharmacy innovation company with an unmatched breadth of capabilities, CVS Caremark continually strives to improve health and lower costs by developing new approaches such as its unique Pharmacy Advisor program that helps people with chronic diseases such as diabetes obtain and stay on their medications.  Find more information about how CVS Caremark is reinventing pharmacy for better health at info.cvscaremark.com.

Media Contact:
Christine Cramer
CVS Caremark
(401) 770-3317 
christine.cramer@cvscaremark.com


'/>"/>
SOURCE CVS Caremark
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. CVS Caremark Reports Record Third Quarter Results
2. Philanthropic Grants, Product Launches, Promising Partnerships, and Customer Satisfaction Rankings - Research Report on CVS Caremark, Walgreens, McKesson, AmerisourceBergen, and Cardinal Health
3. CVS Caremark Research Finds New, More Accurate Method for Classifying Patient Medication Adherence Behaviors
4. CVS Caremark Uses Data to Combat National Prescription Drug Abuse Epidemic; Program Details Published in New England Journal of Medicine Online
5. CVS Caremark Hosts Grand Opening of State-of-the-Art Mail Service Pharmacy and Customer Center
6. CVS Caremarks Accordant Health Services Launches New Member-Focused Web Site
7. CVS Caremark Reports Record Second Quarter Results
8. CVS Caremark Announces Agreement in Principle with the Securities and Exchange Commission
9. CVS Caremark Corporation To Hold Second Quarter 2013 Conference Call
10. CVS Caremark in Partnership with Ocean Conservancy Cleans Up Nearly 25,000 Pounds of Trash from Shorelines across the Country
11. CVS Caremark Corporation Announces Quarterly Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... 2017  IRIDEX Corporation (Nasdaq: IRIX ) ... the first quarter 2017 after the close of trading ... will host a corresponding conference call beginning at 2:30 ... interested in listening to the conference call may do ... (703) 326-3030 for international callers, using conference ID: 92158987.  ...
(Date:4/19/2017)... 19, 2017 Global Prostate Cancer Therapeutics ... the prostate cancer therapeutics market analyzes the current ... prevalence of prostate cancer, launch of promising emerging ... of new drugs & therapeutic biological products, and ... to lesser side effects are some of the ...
(Date:4/19/2017)... PUNE, India , April 19, 2017 ... Type and Application, Forecast to 2022 report has covered and ... provides statistics and information on market size, shares and growth ... with major drivers, challenges and opportunities in the global market. ... Browse 152 Tables and ...
Breaking Medicine Technology:
(Date:4/28/2017)... Manhattan New york (PRWEB) , ... April 28, ... ... is pleased to announce that Aditya Patel M.D. has joined the revolutionary endoscopic ... fellowship training and board certification in Interventional Pain Medicine. The patented, revolutionary eDiscSculpt ...
(Date:4/28/2017)... ... April 28, 2017 , ... People are starting to ... “Wearing a hearing aid doesn’t have the stigma it had when great-grandpa wore his ... of Greater Boston, in a NALA North American Speaker Series (NASS) segment. ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... their work assisting the Brooke Grove Foundation implement a Microsoft Dynamics GP solution ... Solutions, a leading ERP expert that specializes in long-term care, Brooke Grove now ...
(Date:4/28/2017)... ... ... Christie Medical Holdings, Inc. , with its market-leading vein finder ... a leader in infusion therapy and pain management. , Intravenous (IV) therapy plays ... patients receiving a peripheral IV catheter as part of their treatment plan. Many hospitals ...
(Date:4/27/2017)... Minnesota (PRWEB) , ... April 27, 2017 , ... ... and her husband Dan Gasby the 2017 Public Leadership in Neurology Award (PLINA). ... Woodruff, retired professional athlete Tedy Bruschi, Vice President Walter Mondale, actor Michael J. ...
Breaking Medicine News(10 mins):